Bevantolol is a beta-1 adrenoceptor antagonist that has been shown to be as effective as other beta blockers for the treatment of angina pectoris and hypertension. Mechanism of Action Animal... Mechanism of Action Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors.
- Mechanism
- Curator reviewed
Animal experiments confirm both agonist and antagonist effects on alpha-receptors, in addition to antagonist activity at beta-1 receptors. By binding and antagonizing beta-1 receptors Bevantolol inhibits the normal normal epinephrine-mediated sympathetic actions such as increased heart rate. This has the effect of decreasing preload and blood pressure.
- Primary indication
- For the treatment of angina pectoris and hypertension.Curator reviewed
- Formula / weight
- C20H27NO4 · 345.4327 g/mol (avg)
Resolves to
HXLAFSUPPDYFEO-UHFFFAOYSA-NSMILESCOC1=C(OC)C=C(CCNCC(O)COC2=CC=CC(C)=C2)C=C1What you can answer from here — as of September 12, 2026
Which drugs share a target with Bevantolol, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account